Unicycive Therapeutics, Inc. · NASDAQ:UNCY
Great Point Partners LLC reported a 6.24% stake in Unicycive Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Great Point Partners LLC reported a 6.24% stake in Unicycive Therapeutics, Inc., 796,558 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 6.24%
- Shares
- 796,558
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 6.24% | 796,558 |
| Dr. Jeffrey R. Jay, M.D. | 6.24% | 796,558 |
| Ms. Lillian Nordahl | 6.24% | 796,558 |
Source
Related
- Unicycive Therapeutics, Inc.
- Great Point Partners LLC
- Unicycive Therapeutics, Inc. shareholders
- Schedule 13G/A · Great Point Partners LLC · Nov 14, 2025
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 8, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026